BIOMAT Database Logo BIOMAT Database Logo

Vancomycin absorption from the peritoneal cavity during dialysis-related peritonitis. 1990

J Rubin
Department of Medicine, University of Mississippi Medical Center, Jackson 39216-4505.

The uptake of vancomycin from the peritoneal cavity during acute episodes of peritonitis was compared to noninfected patients in 14 patients, 7 of whom had dialysis-related peritonitis. Treatment consisted of 8 hourly dialysate exchanges, followed by 4-h dwells containing 37.5 mg/L of vancomycin. On day 4, serum vancomycin concentrations were 13.4 +/- 4.8 mg/L in the controls and 15.5 +/- 6.8 mg/L in the group with peritonitis. After 180 min in the peritoneal cavity, 61% +/- 13% of the infused vancomycin remained in controls and 30% +/- 15% in patients with peritonitis (p less than 0.05). Uptake of vancomycin from the peritoneal cavity is enhanced during episodes of peritonitis.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010529 Peritoneal Cavity The space enclosed by the peritoneum. It is divided into two portions, the greater sac and the lesser sac or omental bursa, which lies behind the STOMACH. The two sacs are connected by the foramen of Winslow, or epiploic foramen. Greater Sac,Lesser Sac,Omental Bursa,Bursa, Omental,Cavity, Peritoneal,Sac, Greater,Sac, Lesser
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D010538 Peritonitis INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. Primary Peritonitis,Secondary Peritonitis,Peritonitis, Primary,Peritonitis, Secondary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000042 Absorption The physical or physiological processes by which substances, tissue, cells, etc. take up or take in other substances or energy.
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014640 Vancomycin Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear. AB-Vancomycin,Diatracin,VANCO-cell,Vanco Azupharma,Vanco-saar,Vancocin,Vancocin HCl,Vancocine,Vancomicina Abbott,Vancomicina Chiesi,Vancomicina Combino Phar,Vancomicina Norman,Vancomycin Hexal,Vancomycin Hydrochloride,Vancomycin Lilly,Vancomycin Phosphate (1:2),Vancomycin Phosphate (1:2), Decahydrate,Vancomycin Sulfate,Vancomycin-ratiopharm,Vancomycine Dakota,Hydrochloride, Vancomycin,Sulfate, Vancomycin

Related Publications

J Rubin
Peritoneal dialysis-related peritonitis caused by vancomycin-resistant Enterococcus faecium.
February 2011, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,
J Rubin
Vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis in patients with peritonitis.
July 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
J Rubin
Peritoneal dialysis-related peritonitis caused by erosion of umbilical abscess into the peritoneal cavity.
January 2012, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
J Rubin
Intraperitoneal vancomycin concentrations during peritoneal dialysis-associated peritonitis: correlation with serum levels.
January 2012, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
J Rubin
Glucose absorption from the dialysis fluid during peritoneal dialysis.
January 1971, Scandinavian journal of urology and nephrology,
J Rubin
Incidence and significance of peritoneal eosinophilia during peritoneal dialysis-related peritonitis.
January 2003, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
J Rubin
Peritoneal transport of vancomycin during peritoneal dialysis.
January 1979, Nephron,
J Rubin
Evaluation of intraperitoneal vancomycin in peritoneal dialysis-associated peritonitis.
March 2022, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
J Rubin
Vancomycin pharmacokinetics in patients with peritonitis on peritoneal dialysis.
May 1983, Antimicrobial agents and chemotherapy,
J Rubin
Vancomycin-resistant enterococci peritonitis development after shifting from hemodialysis to peritoneal dialysis.
January 2010, Renal failure,
Copied contents to your clipboard!